Biotech and Pharma Rebound Strengthen Thermo’s (TMO) Organic Growth
Lindsell Train Ltd, an investment management company, has released its “Lindsell Train Global Equity Fund” third-quarter 2026 ...
Model output · Signal date 2026-10-14
Thermo Fisher Scientific Inc. (TMO) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Rating · 90D
▼ Bearish
Exact rating locked
90-day forecast
Sign up free to reveal
30-day forecast
Alpha
Rank in coverage
Bottom 35%
of 5379 stocks scored
Rank correlation · 90D
n/a
No per-ticker sample yet
Market Cap
$245.16B
mega-cap · #1 of 9 peers
Summary
Thermo Fisher Scientific Inc. (TMO) stock forecast summary
Our AI ranks Thermo Fisher Scientific Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Thermo Fisher Scientific Inc. is a mega-cap company with a market capitalization of $245.16B. It ranks number 1 by market capitalization among the 9 Measuring & Controlling Devices, NEC issuers in our coverage with a current forecast. Its Net Margin of 15.0% is the highest of the 8 peers that report one.
A per-ticker accuracy statistic for TMO is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, TMO included.
Follow TMO freePrice
TMO price chart and AI forecast
Cross-section · 2026-10-13
How TMO ranks among 5379 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Fundamentals
Thermo Fisher Scientific Inc. (TMO) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Measuring & Controlling Devices, NEC peers listed below that report each metric.
Valuation & Market
| Metric | TMO | Rank |
|---|---|---|
| Market Cap | $245.16B | 1/9 |
| P/E Ratio | 35.19x | – |
| P/B Ratio | 4.65x | 4/9 |
| Dividend Yield | 0.27% | – |
| EPS | $18.59 | – |
| Book Value/Share | $142.47 | – |
| Revenue/Share | $125.32 | – |
| FCF/Share | $19.79 | – |
Profitability & Margins
| Metric | TMO | Rank |
|---|---|---|
| ROE | 13.2% | 2/8 |
| ROA | 6.2% | 3/8 |
| ROIC | 8.3% | 3/9 |
| Operating Margin | 17.6% | 2/10 |
| Net Margin | 15.0% | 1/8 |
| EBT Margin | 16.4% | 1/10 |
| Tax Rate | 7.9% | – |
Financial Health
| Metric | TMO | Rank |
|---|---|---|
| Current Ratio | 1.55x | 6/9 |
| Quick Ratio | 1.18x | 6/9 |
| D/E Ratio | 1.15x | 4/11 |
| Financial Leverage | 2.15x | 4/11 |
| Interest Coverage | 1.4x | 5/9 |
| Working Capital | $8.30B | 1/9 |
Cash Flow
| Metric | TMO | Rank |
|---|---|---|
| Operating Cash Flow | $9.01B | 1/10 |
| Free Cash Flow | $7.32B | 1/8 |
| Capital Spending | -$1.70B | 8/8 |
| OCF Growth YoY | 18.9% | 4/5 |
| FCF Growth YoY | 18.6% | – |
| FCF/Sales | 15.8% | 3/8 |
| CapEx/Sales | 3.7% | 4/8 |
Operational Efficiency
| Metric | TMO | Rank |
|---|---|---|
| Asset Turnover | 0.41x | 6/8 |
| Receivables Turnover | 4.9x | 6/8 |
| Fixed Assets Turnover | 4.3x | 6/8 |
| Days Sales Outstanding | 74 days | 3/8 |
Income Statement
| Metric | TMO | Rank |
|---|---|---|
| Total Revenue | $46.34B | 1/8 |
| Operating Income | $8.15B | 1/10 |
| Net Income | $6.97B | 1/8 |
| R&D Expense | $1.40B | 1/10 |
| SG&A Expense | $9.03B | 1/10 |
Dividend & Shareholder Information
| Metric | TMO | Rank |
|---|---|---|
| Dividends Per Share | $1.79 | – |
| Payout Ratio | 9.6% | – |
| Shares Outstanding | 370M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $23.36B | 20.6% of assets |
| Cash & Short-term Investments | $4.06B | 3.6% of assets |
| Accounts Receivable | $9.45B | 8.4% of assets |
| Inventory | $5.63B | 5.0% of assets |
| Total Liabilities | $60.49B | 53.4% of assets |
| Short-term Debt | $11.80B | 10.4% of assets |
Quarterly Financial Reports
TMO quarterly financials and insider trading
Industry Peers · Measuring & Controlling Devices, NEC
Thermo Fisher Scientific Inc. (TMO) industry peers
Companies classified under the same SEC industry code as Thermo Fisher Scientific Inc. (Measuring & Controlling Devices, NEC): 11 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| TMO Thermo Fisher Scientific Inc. | ▼ | $245.16B |
| ROK Rockwell Automation, Inc | ▼ | $48.01B |
| TRMB Trimble Inc. | ▼ | $13.99B |
| ONTO Onto Innovation Inc. | ▶ | $12.93B |
| MIR Mirion Technologies, Inc. | ▶ | $4.09B |
| OWLT Owlet, Inc. | ▶ | $135M |
| GEOS Geospace Technologies Corp | ▲ | $61M |
| BCHT Birchtech Corp. | ▶ | $37M |
| NIKI Niki Biosolutions, Inc. | ▼ | $2M |
| AATC Autoscope Technologies Corp | ▶ | N/A |
| QSI Quantum-Si Inc | ▶ | N/A |
Where TMO sits on the market map
Industrial Applications and Services · Measuring & Controlling Devices, NEC
News
Thermo Fisher Scientific Inc. (TMO) stock news
Thermo Fisher Stock Trades at a Premium. Can Its Earnings Keep Up?
Thermo Fisher Scientific, Inc. (NYSE:TMO) is having a good year, with shares surging by over 11% so far. The stock’s ...
Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights
Expected to be immediately accretive to Adjusted Earnings Per Share (EPS)¹ after close Attractive return profile given high growth and strong margin profile of Clario, and meaningful synergies - ...
FAQ
Thermo Fisher Scientific Inc. (TMO) stock forecast FAQ
What is the Thermo Fisher Scientific Inc. (TMO) stock forecast?
Our AI ranks Thermo Fisher Scientific Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Thermo Fisher Scientific Inc. stock predictions?
A per-ticker accuracy statistic for TMO is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Thermo Fisher Scientific Inc. forecasts updated?
Thermo Fisher Scientific Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Thermo Fisher Scientific Inc.'s industry peers?
11 issuers in our coverage, TMO included, share the SEC industry code Measuring & Controlling Devices, NEC. The largest are: Rockwell Automation, Inc (ROK), Trimble Inc. (TRMB), Onto Innovation Inc. (ONTO), Mirion Technologies, Inc. (MIR), Owlet, Inc. (OWLT), Geospace Technologies Corp (GEOS).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.